Longitudinal Assessment of FEV1 Change Following Autologous Cellular Therapy

Journal Title: Journal of Regenerative Medicine & Biology Research - Year 2021, Vol 1, Issue 1

Abstract

Objective: Current pharmacologic management of Chronic Obstructive Pulmonary Disease (COPD) is aimed at improving symptoms and preventing exacerbations, yet none can alter the natural progression of lung function decline typical of the disease. Autologous-derived PRPPC may prevent lung function decline and improve quality of life. Methods: 281 patients with COPD underwent autologous cellular therapy with PRP-PC. Baseline lung function and quality of life data were collected and re-assessed after 3 months and after at least 12 months and compared to baseline. Results: Participants undergoing autologous cellular therapy with PRP-PC had a and clinically significant increase in lung function after both 3 months and after at least one year with along with a significant improvement in subjective quality of life from baseline. Compared with findings in the literature that FEV1 typically declines over time, participants in this study had a significant increase in lung function on average. Conclusion: Innovative treatments such as autologous cellular therapy can be a safe, effective option for preventing lung function decline over time. These therapies should be an option for patients where pharmacologic management has failed, or as an adjunct treatment.

Authors and Affiliations

Melissa M Rubio

Keywords

Related Articles

Platelet Rich Plasma- Platelet Concentrate Therapy in COPD: An Observational Cohort Study

Objective: Current management of Chronic Obstructive Pulmonary Disease (COPD) is aimed at improving symptoms and preventing exacerbations, yet those treatments cannot alter the natural progression of lung function decl...

Use of Circularly Polarized Light on the Evaluation of Injectable Platelet Rich Fibrin in the Early Formation of Woven and Lamellar Bone: A Specific Method in the Study of Osseous Tissue

Purpose: In bone grafting, the goal is the formation of 100% vital bone. The ideal graft material is osteogenic, osteoconductive and osteoinductive and can be evaluated by histology and histomorphometric methods to calcu...

The Use of Stem Cell Therapy in the Treatment of Autism Spectrum Disorder

Research on the use of stem cell therapy in regenerative medicine has shown great potential in the treatment of neurological disorders. Specifically, mesenchymal stem cells, adult stem cells from the umbilical cord and e...

Adipose-Derived Stem Cells: Isolation and Utilization within Regenerative Medicine and Cosmetic Procedures

Adipose-derived stem cells are a promising tool for the future of reconstructive surgeries, regenerative therapies and cosmetic procedures. Their ability to be safely, efficiently and cost-effectively isolated from extra...

Jejunal Atresia with Hirschsprung’s Disease: A Case Report

A rare case of congenital intestinal atresia associated with Hirschsprung disease was reported. A 0-day-old boy who was diagnosed to have intestinal atresia and he underwent intestinal anastomosis. The movement of the...

Download PDF file
  • EP ID EP698851
  • DOI http://dx.doi.org/10.46889/JRMBR.2021.2101
  • Views 63
  • Downloads 0

How To Cite

Melissa M Rubio (2021). Longitudinal Assessment of FEV1 Change Following Autologous Cellular Therapy. Journal of Regenerative Medicine & Biology Research, 1(1), -. https://europub.co.uk/articles/-A-698851